Albert Lockhart

Professor

  • 4227 Citations
1977 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Albert Lockhart is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 11 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

  • Research Output

    • 4227 Citations
    • 95 Article
    • 18 Review article
    • 7 Comment/debate
    • 1 Letter

    A Phase Ib Study to Evaluate the MEK Inhibitor Cobimetinib in Combination with the ERK1/2 Inhibitor GDC-0994 in Patients with Advanced Solid Tumors

    Weekes, C., Lockhart, A., LoRusso, P., Murray, E., Park, E., Tagen, M., Singh, J., Sarkar, I., Mueller, L., Dokainish, H., Shapiro, G. & Burris, H., Jan 1 2020, (Accepted/In press) In : Oncologist.

    Research output: Contribution to journalArticle

    Open Access
  • First-In-Human Study of Cemiplimab Alone or in Combination with Radiotherapy and/or Low-dose Cyclophosphamide in Patients with Advanced Malignancies

    Papadopoulos, K. P., Johnson, M. L., Lockhart, A. C., Moore, K., Falchook, G. S., Formenti, S. C., Naing, A., Carvajal, R. D., Rosen, L. S., Weiss, G. J., Leidner, R. S., Li, J., Paccaly, A., Feng, M., Stankevich, E., Lowy, I., Fury, M. G. & Crittenden, M. R., Mar 1 2020, In : Clinical Cancer Research. 26, 5, p. 1025-1033 9 p.

    Research output: Contribution to journalArticle

    Open Access
  • 2 Scopus citations

    FOLFIRINOX for the Treatment of Advanced Gastroesophageal Cancers: A Phase 2 Nonrandomized Clinical Trial

    Park, H., Jin, R. U., Wang-Gillam, A., Suresh, R., Rigden, C., Amin, M., Tan, B. R., Pedersen, K. S., Lim, K. H., Trikalinos, N. A., Acharya, A., Copsey, M. L., Navo, K. A., Morton, A. E., Gao, F. & Lockhart, A. C., 2020, (Accepted/In press) In : JAMA Oncology.

    Research output: Contribution to journalArticle

  • Long non-coding RNA RAMS11 promotes metastatic colorectal cancer progression

    Silva-Fisher, J. M., Dang, H. X., White, N. M., Strand, M. S., Krasnick, B. A., Rozycki, E. B., Jeffers, G. G. L., Grossman, J. G., Highkin, M. K., Tang, C., Cabanski, C. R., Eteleeb, A., Mudd, J., Goedegebuure, S. P., Luo, J., Mardis, E. R., Wilson, R. K., Ley, T. J., Lockhart, A. C., Fields, R. C. & 1 others, Maher, C. A., Dec 1 2020, In : Nature communications. 11, 1, 2156.

    Research output: Contribution to journalArticle

    Open Access
  • Pan-Cancer Efficacy of Vemurafenib in BRAFV600-Mutant Non-Melanoma Cancers

    Subbiah, V., Puzanov, I., Blay, J. Y., Chau, I., Lockhart, A. C., Raje, N. S., Wolf, J., Baselga, J., Meric-Bernstam, F., Roszik, J., Diamond, E. L., Riely, G. J., Sherman, E. J., Riehl, T., Pitcher, B. & Hyman, D. M., May 1 2020, In : Cancer discovery. 10, 5, p. 657-663 7 p.

    Research output: Contribution to journalArticle

    Open Access
  • 2 Scopus citations